5.03

2.65% 0.13

After Hours: 6.41 1.38 +27.44%

Advanced Biomed Inc (ADVB)

Overview News Price History Discussions Forecast

Advanced Biomed Inc stock is traded at $5.03, with a volume of 10,282. It is up +2.65% in the last 24 hours and up +5.89% over the past month. Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Previous Close:

$4.90

Open:

$5.12

24h Volume:

10,282

Relative Volume:

0.10

Market Cap:

$8.31M

Revenue:

Net Income/Loss:

$174.50K

P/E Ratio:

31.60

EPS:

0.1592

Net Cash Flow:

$-102.70K

1W Performance:

-2.52%

1M Performance:

+5.89%

6M Performance:

-15.03%

1Y Performance:

-65.86%

1-Day Range:

$4.92

$5.2464

1-Week Range:

$4.87

$5.5664

52-Week Range:

$3.61

$15.20

Advanced Biomed Inc Stock (ADVB) Company Profile

Name

Advanced Biomed Inc

Sector

Healthcare (1092)

Industry

Diagnostics & Research (49)

Phone

86-21-20510823

Address

401 RYLAND ST, RENO

Employee

Twitter

Next Earnings Date

2026-05-21

Latest SEC Filings

ADVB's Discussions on Twitter

Compare ADVB vs TMO, DHR, IDXX, NTRA, A

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ADVB Advanced Biomed Inc	5.03	8.10M	0	174.50K	-102.70K	0.1592
TMO Thermo Fisher Scientific Inc	532.48	201.86B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	203.83	145.10B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	567.44	45.44B	4.45B	1.10B	1.06B	13.59
NTRA Natera Inc	271.39	38.64B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	131.46	38.44B	7.23B	1.41B	1.09B	4.979

Advanced Biomed Inc Stock (ADVB) Latest News

Jul 17, 2026

Trending Stocks Today | Advanced Biomed Surges 41.46% Post-Market - Moomoo

Jul 17, 2026

Advanced Biomed Delivers Notice To Terminate Purchase Agreement With With Helena Global Investment Opportunities I Ltd On July 14SEC Filing - TradingView

Jul 17, 2026

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Jul 17, 2026

Advanced Biomed Terminates $25M Equity Purchase Pact With Helena Global Investment Opportunities I - TradingView

Jul 17, 2026

Advanced Biomed (ADVB) to terminate $25M equity purchase deal with Helena investor - Stock Titan

Jul 17, 2026

Jul 13, 2026

Island Pharmaceuticals Signs Statement of Work With Texas Biomed to Advance Galidesivir, Shares Hit Six Month High - Moomoo

Jul 13, 2026

Jul 12, 2026

Number of shareholders of Advanced Biomed Inc. – NASDAQ:ADVB - TradingView

Jul 12, 2026

Jul 08, 2026

Price to book forward of Advanced Biomed Inc. – NASDAQ:ADVB - TradingView

Jul 08, 2026

Enterprise value to revenue forward of Advanced Biomed Inc. – NASDAQ:ADVB - TradingView

Jul 08, 2026

Jul 07, 2026

Price to earnings forward of Advanced Biomed Inc. – NASDAQ:ADVB - TradingView

Jul 07, 2026

Jul 06, 2026

Enterprise value to EBIT forward of Advanced Biomed Inc. – NASDAQ:ADVB - TradingView

Jul 06, 2026

Price to sales forward of Advanced Biomed Inc. – NASDAQ:ADVB - TradingView

Jul 06, 2026

Auburn University to introduce biomedical engineering graduate and certificate programs - Morningstar

Jul 06, 2026

Jul 02, 2026

ADVBAdvanced Biomed Inc Earnings - Finviz

Jul 02, 2026

Jul 01, 2026

Advanced Biomed Inc. 8-K Filing: Company Details, Emerging Growth Status, and Nasdaq Listing for 2026 - Minichart

Jul 01, 2026

Advanced Biomed Stockholders Back Board and Governance Decisions - TipRanks

Jul 01, 2026

Advanced Biomed (NASDAQ: ADVB) investors approve all 2026 meeting proposals - Stock Titan

Jul 01, 2026

Jun 30, 2026

Advanced Biomed Inc. Sells Taiwan Subsidiary for $490,000 in Share Purchase Agreement – Nasdaq: ADVB 8-K Filing - Minichart

Jun 30, 2026

Advanced BiomedTo Sell Taiwan Subsidiary For $490,000SEC Filing - TradingView

Jun 30, 2026

Advanced Biomed Divests Taiwan R&D Unit, Refocuses on AI - TipRanks

Jun 30, 2026

12 Health Care Stocks Moving In Tuesday's After-Market SessionAlzamend Neuro (NASDAQ:ALZN), Vivos Ther - Benzinga

Jun 30, 2026

Advanced Biomed to Divest Taiwan Subsidiary for $490,000; Closing Expected Within Three Months - TradingView

Jun 30, 2026

Advanced Biomed (NASDAQ: ADVB) selling Taiwan R&D subsidiary for $490K - Stock Titan

Jun 30, 2026

Jun 29, 2026